| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
9e-05 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0003 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |